isoxazoles has been researched along with Hyperprolactinaemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V | 1 |
| Boot, AM; Buitelaar, JK; Franke, B; Galesloot, TE; Roke, Y; van Harten, PN | 1 |
| Creus, M; Franch, J; Gutiérrez-Zotes, A; Labad, J; Lawrie, SM; Monseny, R; Montalvo, I; Ortega, L; Reynolds, RM; Vilella, E | 1 |
| Chen, CC; Chiu, CC; Huang, MC; Pan, CH; Peng, PW; Tsai, CJ | 1 |
| Manoj, P; Skopek, M | 1 |
| Hara, C; Ramos, MG; Rocha, FL | 1 |
| Coppola, D; Einarson, TR; Gopal, S; Hemels, ME; Hough, D; Nuamah, I | 1 |
| Franch, J; Labad, J; López, X; Monseny, R; Montalvo, I; Ortega, L; Solé, M; Vilella, E | 1 |
| Boot, AM; Buitelaar, JK; Roke, Y; Tenback, D; van Harten, PN | 1 |
| Baselmans, P; Bosker, F; Bruggeman, R; Castelein, S; Knegtering, R; van den Bosch, RJ | 1 |
| Dalby, JT; Dickson, RA; Edwards, AL; Williams, R | 1 |
1 review(s) available for isoxazoles and Hyperprolactinaemia
| Article | Year |
|---|---|
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics | 2013 |
2 trial(s) available for isoxazoles and Hyperprolactinaemia
| Article | Year |
|---|---|
The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology | 2008 |
An analysis of potentially prolactin-related adverse events and abnormal prolactin values in randomized clinical trials with paliperidone palmitate.
Topics: Adult; Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Prolactin; Young Adult | 2012 |
8 other study(ies) available for isoxazoles and Hyperprolactinaemia
| Article | Year |
|---|---|
The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
Topics: Adolescent; Alleles; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Genetic Variation; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Pyrimidines; Receptors, Dopamine D2; Risperidone; Young Adult | 2013 |
Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Cognition; Cognition Disorders; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Young Adult | 2014 |
Hyperprolactinaemia during treatment with paliperidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Galactorrhea; Humans; Hyperprolactinemia; Isoxazoles; Middle Aged; Paliperidone Palmitate; Patient Compliance; Piperazines; Prolactin; Psychotic Disorders; Pyrimidines; Quetiapine Fumarate; Quinolones; Recurrence; Schizophrenia, Paranoid; Young Adult | 2010 |
Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Schizophrenia, Paranoid; Treatment Outcome | 2010 |
Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
Topics: Adult; Age Factors; Antipsychotic Agents; Biomarkers; Drug Substitution; Female; Humans; Hyperprolactinemia; Injections; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recovery of Function; Risperidone; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2013 |
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cross-Sectional Studies; Dose-Response Relationship, Drug; Gynecomastia; Humans; Hyperprolactinemia; Isoxazoles; Logistic Models; Male; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Young Adult | 2012 |
Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone | 2005 |
Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.
Topics: Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Isoxazoles; Piperidines; Premenopause; Prolactin; Risperidone; Schizophrenia | 1995 |